Ati cautat: reactii adverse medicamente
Protocol terapeutic: A16AB17 – DCI CERLIPONASUM ALFA (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: L04AC11 – DCI SILTUXIMABUM (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: L01XX50 – DCI IXAZOMIB (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: L01XE39 – DCI MIDOSTAURINUM (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: L01XE28 – DCI CERITINIBUM (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: L01XE12 – DCI VANDETANIBUM (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: L01XC02 – DCI RITUXIMABUM (ORIGINAL ȘI BIOSIMILAR) (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: L01BC59 – DCI COMBINAŢII (TRIFLURIDINUM + TIPIRACILUM) (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: A10BJ02 DCI LIRAGLUTIDUM (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: A10AE06 – DCI INSULINUM DEGLUDEC (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
